Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank27
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-25.40%
↓ 44% vs avg
Percentile
P27
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-17.61%
Historical baseline
PeriodValue
Q4 2025-25.40%
Q3 2025-0.72%
Q2 2025-11.09%
Q1 2025-20.44%
Q4 2024-13.93%
Q3 20243.22%
Q2 202420.06%
Q1 2024-67.68%
Q4 2023-55.23%
Q3 2023-35.84%
Q2 2023-4.29%
Q1 20230.00%